Andrew Conrad is a renowned geneticist who is running Alphabet’s (Google’s holding company) life sciences division called Verily.
In 1991 Conrad co-founded the National Genetics Institute (NGI) along with Mike Aicher. He served as its chief scientist and helped grow it into one of the largest genetics laboratories in the world.
In March 2013 Conrad joined the life sciences unit of Google X after 22 years at NGI. In August 2015 the life sciences unit of Google X was spun out as its own company under the Alphabet Inc. with Conrad as its CEO. In December 2015, the company changed its name from Google Life Sciences to Verily.
Verily is working on a number of devices ranging from wearables to nanoparticle powered handheld ‘tricorder’. Verily’s eyewear, used to detect diabetes by analysing glucose content in tears and a smartwatch which can monitor the user’s heart function using a micro ECG device, are already in use across labs around the world.